John J. Grande, CFP, and John S. Grande, CFP, of Grande Financial Services, speak on how ophthalmologists should be working on or revisiting their financial plans six months into the ongoing coronavirus pandemic and ahead of a possible second wave, as well as the potential financial repercussions the economy may face.
Epioxa is a next-generation corneal cross-linking iLink therapy for the treatment of keratoconus.
Enhancing durability and reducing treatment burden.
Investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice.
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Epioxa is a next-generation corneal cross-linking iLink therapy for the treatment of keratoconus.
Enhancing durability and reducing treatment burden.
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice.
The report details the results of preclinical discovery, engineering and characterization studies evaluating the safety, retinal cell transduction, transgene expression and clinical activity of proprietary…
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
